| Application no. and date | 13753131.5 (espacenet) (Federated) (European Patent Register), 20130815 | | Patent/reg. no. and date | DK/EP 2884979, 20190626 | | Publication date | 20150624 | | Priority no. and date | US 201261684673 P, 20120817, US 201261705575 P, 20120925, US 201261706026 P, 20120926, US 201261722725 P, 20121105, US 201361780708 P, 20130313 | | EP pub. no. and date |
EP 2884979 20150624 | | Effective date | | | Applicant/owner | F. Hoffmann-La Roche AG, Grenzacherstrasse 124
4070 Base, CH | | Applicant ref. no. | P69396DK01 | | Inventor | BRAY, Gordon, c/o Genentech Inc.
1 DNA Way
South San Francisco, CA 94080, US,
CHAN, Iris, T., c/o Genentech Inc.
1 DNA Way
South San Francisco, CA 94080, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 31/437 (2006.01) , A61K 31/4523 (2006.01) , A61P 35/00 (2006.01) , A61P 35/04 (2006.01) , C12Q 1/68 (2018.01) , C12Q 1/6886 (2018.01) , G06Q 30/02 (2012.01) | | Title | Kombinationsbehandlinger mod melanom omfattende indgivelse af cobimetinib og vemurafenib | | Int. application no. | EP2013067050 | | Int. publication no. | WO2014027056 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
